In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
Supplement groups urge NIH to retain independent dietary supplements office
The associations linked their call for sustained supplement research to the administration’s Make America Healthy Again priorities, citing recognition of the health benefits of select high-quality supplements as an area warranting scientific investigation.
WK Kellogg Co celebrates more than a century of nutrition innovation during American Archives Month
The company's newly built Corporate Archives spans more than 3,500 square feet and houses more than 30,000 items, including historic packaging, advertising and marketing materials, artwork, memorabilia and audiovisual assets
CHPA expands membership with 14 new companies
“These companies reflect the breadth of self-care options available to consumers today and the diverse industry CHPA is proud to represent."
Walmart expands Better Care Services with healthcare comparison platform
“At Walmart, we’re always looking for ways to make the customer experience simpler and more useful.”